Moody’s has also affirmed the “A2” rating on the system’s outstanding bonds.
The rating assignment is based on several factors, including the system’s position as a large system in the Cleveland area as well as its manageable capital spending plans.
Challenges to the system include balance sheet and operating leverage and the presence of a large and prominent competitor.
The rating outlook is stable, reflecting expected continued adequate margins and no major increase in leverage.
More articles on finance:
Applying bundled payments to perioperative services: 3 major takeaways
Ascension sees operating margin increase on higher patient volume: 6 things to know
8 recent hospital outlook and credit rating actions
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
